Invited commentary: Interpreting associations between exposure biomarkers and pregnancy outcome

American Journal of Epidemiology

Volumn 179, Issue 5, 2014, Pages 545-547

  Savitz, David A ^a  

^a BROWN UNIVERSITY   (United States)

Author keywords

Biomarkers; Fetal growth; Pregnancy; Preterm birth; Reverse causality

Indexed keywords

BIOLOGICAL MARKER;

BIOMARKER; BIRTH DATE; ENVIRONMENTAL IMPACT; HEALTH RISK; METABOLISM; POLLUTION EXPOSURE; PREGNANCY;

BEHAVIOR CHANGE; CORRELATIONAL STUDY; ENVIRONMENTAL EXPOSURE; EPIDEMIOLOGY; MEDICAL INFORMATION; METABOLISM; PREGNANCY OUTCOME; REVIEW;

BIOMARKERS; FETAL GROWTH; PREGNANCY; PRETERM BIRTH; REVERSE CAUSALITY;

CHLORDECONE; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL POLLUTANTS; FEMALE; HUMANS; INSECTICIDES; PREGNANCY; PREMATURE BIRTH;

EID: 84896692118     PISSN: 00029262     EISSN: 14766256     Source Type: Journal    
DOI: 10.1093/aje/kwt314     Document Type: Review

References (6)

1. Kadhel P, Monfort C, Costet N, et al. Chlordecone exposure, length of gestation, and risk of preterm birth. Am J Epidemiol. 2014;179(5):536-544.
2. Salas SP, Marshall G, Gutierrez BL, et al. Time course of maternal plasma volume and hormonal changes in women with preeclampsia or fetal growth restriction. Hypertension. 2006; 47(2):203-208.
3. Faupel-Badger JM, Hsieh C-C, Troisi R, et al. Plasma volume expansion in pregnancy: implications for biomarkers in population studies. Cancer Epidemiol Biomarkers Prev. 2007; 16(9):1720-1723.
4. Hutcheon JA, Lisonkova S, Joseph KS. Epidemiology of pre-eclampsia and the other hypertensive disorders of pregnancy. Best Pract Res Clin Obstet Gynaecol. 2011;25(4): 391-403.
5. Franceschini N, Savitz DA, Kaufman JS, et al. Maternal urine albumin excretion and pregnancy outcome. Am J Kidney Dis. 2005;45(6):1010-1018.
6. Braun JM, Smith KW, Williams PL, et al. Variability of urinary phthalate metabolite and bisphenol A concentrations before and during pregnancy. Environ Health Perspect. 2012;120(5): 739-745.